SG11202011382PA - Polycyclic carbamoylpyridone derivative - Google Patents

Polycyclic carbamoylpyridone derivative

Info

Publication number: SG11202011382PA
Authority: SG; Singapore
Prior art keywords: polycyclic carbamoylpyridone; carbamoylpyridone derivative; derivative; polycyclic; carbamoylpyridone
Prior art date: 2018-05-31

Application number

SG11202011382PA

Inventor

Yoshiyuki Taoda

Yuto UNOH

Original Assignee

Shionogi & Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2018-05-31

Filing date

2019-05-30

Publication date

2020-12-30

2019-05-30 Application filed by Shionogi & Co filed Critical Shionogi & Co

2020-12-30 Publication of SG11202011382PA publication Critical patent/SG11202011382PA/en

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/14—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5386—1,4-Oxazines, e.g. morpholine spiro-condensed or forming part of bridged ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/18—Bridged systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/20—Spiro-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed systems contains four or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Virology (AREA)
Epidemiology (AREA)
Tropical Medicine & Parasitology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
AIDS & HIV (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Molecular Biology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Pyridine Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

SG11202011382PA 2018-05-31 2019-05-30 Polycyclic carbamoylpyridone derivative SG11202011382PA (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP2018104156		2018-05-31
PCT/JP2019/021446 WO2019230858A1 (en)	2018-05-31	2019-05-30	Polycyclic carbamoylpyridone derivative

Publications (1)

Publication Number	Publication Date
SG11202011382PA true SG11202011382PA (en)	2020-12-30

Family

ID=68698918

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SG11202011382PA SG11202011382PA (en)	2018-05-31	2019-05-30	Polycyclic carbamoylpyridone derivative

Country Status (35)

Country	Link
US (3)	US11649236B2 (en)
EP (2)	EP4257137A3 (en)
JP (2)	JP7328962B2 (en)
KR (2)	KR20250002769A (en)
CN (2)	CN117327072A (en)
AR (1)	AR115455A1 (en)
AU (2)	AU2019277548B2 (en)
BR (1)	BR112020024077A2 (en)
CA (1)	CA3102063A1 (en)
CL (1)	CL2020003002A1 (en)
CO (1)	CO2020014294A2 (en)
CR (2)	CR20200644A (en)
DK (1)	DK3805220T3 (en)
DO (1)	DOP2020000221A (en)
EA (1)	EA202092921A1 (en)
ES (1)	ES2984245T3 (en)
FI (1)	FI3805220T3 (en)
HR (1)	HRP20241221T1 (en)
HU (1)	HUE068170T2 (en)
IL (2)	IL279051B2 (en)
LT (1)	LT3805220T (en)
MA (1)	MA52795B1 (en)
MD (1)	MD3805220T2 (en)
MX (2)	MX2020012176A (en)
PE (1)	PE20210477A1 (en)
PH (1)	PH12020552000A1 (en)
PL (1)	PL3805220T3 (en)
PT (1)	PT3805220T (en)
RS (1)	RS65891B1 (en)
SG (1)	SG11202011382PA (en)
SI (1)	SI3805220T1 (en)
SM (1)	SMT202400330T1 (en)
UA (1)	UA129229C2 (en)
WO (1)	WO2019230858A1 (en)
ZA (1)	ZA202007567B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PL3938047T3 (en)	2019-03-22	2022-11-07	Gilead Sciences, Inc.	Bridged tricyclic carbamoylpyridone compounds and their pharmaceutical use
US20230058677A1 (en) *	2019-11-28	2023-02-23	Shionogi & Co., Ltd.	Polycyclic pyridopyrazine derivative
JPWO2021107066A1 (en) *	2019-11-28	2021-06-03
AU2021225809B2 (en)	2020-02-24	2023-08-24	Gilead Sciences, Inc.	Tetracyclic compounds for treating HIV infection
JP7407976B2 (en) *	2020-05-21	2024-01-04	シーセンファーマシューティカルカンパニーリミテッド	Fused ring derivatives and their pharmaceutical uses
MX2023001194A (en) *	2020-07-27	2023-04-20	Merck Sharp & Dohme Llc	Polycyclic cap-dependent endonuclease inhibitors for treating or preventing influenza.
TW202222798A (en)	2020-09-30	2022-06-16	美商基利科學股份有限公司	Bridged tricyclic carbamoylpyridone compounds and uses thereof
PT4196479T (en)	2021-01-19	2024-01-03	Gilead Sciences Inc	SUBSTITUTED PYRIDOTRIAZINE COMPOUNDS AND THEIR USES
CN117751118A (en) *	2021-07-30	2024-03-22	吉斯凯(苏州)制药有限公司	Macrocyclic pyridone compounds and application thereof
TWI843506B (en)	2022-04-06	2024-05-21	美商基利科學股份有限公司	Bridged tricyclic carbamoylpyridone compounds and uses thereof
WO2024061257A1 (en) *	2022-09-20	2024-03-28	吉斯凯(苏州)制药有限公司	Polycyclic n-heterocyclic ketone compound and use thereof

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2003267098B2 (en)	2002-09-11	2008-11-20	Merck & Co., Inc.	Dihydroxypyridopyrazine-1,6-dione compounds useful as HIV integrase inhibitors
US7414045B2 (en)	2002-12-27	2008-08-19	Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A.	Substituted pyrimido[1,2-a]azepines useful as HIV integrase inhibitors
TW200510425A (en)	2003-08-13	2005-03-16	Japan Tobacco Inc	Nitrogen-containing fused ring compound and use thereof as HIV integrase inhibitor
US7858788B2 (en)	2005-02-21	2010-12-28	Shionogi & Co., Ltd.	Bicyclic carbamoylpyridone derivative having HIV integrase inhibitory activity
EP2527007B1 (en)	2005-04-28	2016-03-30	VIIV Healthcare Company	Polycyclic carbamoylpyridone derivative having HIV integrase inhibitory activity
EP1950212B1 (en)	2005-10-27	2016-02-24	Shionogi Co., Ltd.	Polycyclic carbamoylpyridone derivative having inhibitory activity on hiv integrase
RU2012140961A (en)	2010-02-26	2014-04-10	Джапан Тобакко Инк.	DERIVATIVE OF 1,3,4,8-TETRAHYDRO-2H-PYRIDO [1,2-a] PYRAZINE AND ITS APPLICATION AS AN HIV INTEGRASE INHIBITOR
WO2011129095A1 (en)	2010-04-12	2011-10-20	塩野義製薬株式会社	Pyridone derivative having integrase inhibitory activity
JP6163428B2 (en)	2011-10-12	2017-07-12	塩野義製薬株式会社	Polycyclic pyridone derivatives having integrase inhibitory activity
EP2931730B1 (en)	2012-12-17	2019-08-07	Merck Sharp & Dohme Corp.	4-pyridinonetriazine derivatives as hiv integrase inhibitors
CA3012242C (en)	2012-12-21	2021-11-02	Gilead Sciences, Inc.	Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
US20140221378A1 (en)	2012-12-27	2014-08-07	Japan Tobacco Inc.	SUBSTITUTED SPIROPYRIDO[1,2-a]PYRAZINE DERIVATIVE AND PHARMACEUTICAL USE OF SAME AS HIV INTEGRASE INHIBITOR
EP2997033B1 (en)	2013-05-17	2017-11-15	Merck Sharp & Dohme Corp.	Fused tricyclic heterocyclic compounds as hiv integrase inhibitors
EP3008044B1 (en) *	2013-06-13	2018-11-21	Merck Sharp & Dohme Corp.	Fused tricyclic heterocyclic compounds as hiv integrase inhibitors
NO2865735T3 (en)	2013-07-12	2018-07-21
CA2916993C (en)	2013-07-12	2019-01-15	Gilead Sciences, Inc.	Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
WO2015039348A1 (en)	2013-09-23	2015-03-26	Merck Sharp & Dohme Corp.	Tetracyclic heterocycle compounds useful as hiv integrase inhibitors
HK1221648A1 (en)	2013-09-27	2017-06-09	Merck Sharp & Dohme Corp.	Substituted quinolizine derivatives useful as hiv integrase inhibitors
WO2015089847A1 (en) *	2013-12-20	2015-06-25	Merck Sharp & Dohme Corp.	Spirocyclic heterocycle compounds useful as hiv integrase inhibitors
WO2015199167A1 (en)	2014-06-25	2015-12-30	日本たばこ産業株式会社	METHOD FOR PRODUCING SUBSTITUTED SPIROPYRIDO[1,2-a]PYRAZINE DERIVATIVE, AND INTERMEDIATE
JPWO2016027879A1 (en)	2014-08-22	2017-06-01	塩野義製薬株式会社	Polycyclic pyridone derivatives having integrase inhibitory activity
US10150780B2 (en)	2014-12-09	2018-12-11	Merck Sharp & Dohme Corp.	Spirocyclic heterocycle compounds useful as HIV integrase inhibitors
WO2016090545A1 (en)	2014-12-09	2016-06-16	Merck Sharp & Dohme Corp.	Spirocyclic heterocycle compounds useful as hiv integrate inhibitors
TWI695003B (en)	2014-12-23	2020-06-01	美商基利科學股份有限公司	Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
WO2016154527A1 (en)	2015-03-26	2016-09-29	Merck Sharp & Dohme Corp.	Phosphate-substituted quinolizine derivatives useful as hiv integrase inhibitors
MX2017012393A (en)	2015-04-02	2018-02-21	Gilead Sciences Inc	Polycyclic-carbamoylpyridone compounds and their pharmaceutical use.
WO2016187788A1 (en)	2015-05-25	2016-12-01	Merck Sharp & Dohme Corp.	Fused tricyclic heterocyclic compounds useful for treating hiv infection
US10624912B2 (en)	2015-11-17	2020-04-21	Merck Sharp & Dohme Corp.	Spirocyclic Pyridotriazine Derivatives useful as HIV integrase inhibitors
US10548910B2 (en)	2015-11-17	2020-02-04	Merck Sharp & Dohme Corp.	Amido-substituted pyridotriazine derivatives useful as HIV integrase inhibitors
EP3389380B1 (en)	2015-12-15	2021-07-21	Merck Sharp & Dohme Corp.	Spirocyclic quinolizine derivatives useful as hiv integrase inhibitors
WO2017113288A1 (en)	2015-12-31	2017-07-06	Merck Sharp & Dohme Corp.	Fused tricyclic heterocyclic compounds as hiv integrase inhibitors
JOP20190130A1 (en)	2016-12-02	2019-06-02	Merck Sharp & Dohme	Tetracyclic heterocyclic compounds useful as integrated enzyme inhibitors for human immunodeficiency virus (HIV)
BR112019011074B1 (en)	2016-12-02	2021-01-19	Merck Sharp & Dohme Corp.	TRICYCLIC HETEROCYCLIC COMPOUNDS INHIBITORS OF HIV INTEGRASE, COMPOSITION THAT COMPOSES AND USE OF THE SAME
EP3752144B1 (en)	2018-02-15	2022-12-28	Merck Sharp & Dohme LLC	Tricyclic heterocycle compounds useful as hiv integrase inhibitors
AU2019260608A1 (en)	2018-04-27	2020-10-29	Merck Sharp & Dohme Corp.	Tricyclic Heterocycle Compounds useful as HIV integrase inhibitors
CN110526930B (en)	2018-05-23	2022-06-03	莫云芬	anti-HIV (human immunodeficiency virus) sulfur-containing polycyclic-hydroxypyridone formamide analogue and application thereof
SG11202011386QA (en)	2018-05-31	2020-12-30	Shionogi & Co	Polycyclic pyridone derivative
EP3801543B1 (en)	2018-06-05	2024-09-11	Merck Sharp & Dohme LLC	Tricyclic heterocycle compounds useful as hiv integrase inhibitors
CN108957755B (en)	2018-07-27	2021-04-30	京东方科技集团股份有限公司	Display assembly, control method thereof, head-up display and automobile
PL3938047T3 (en)	2019-03-22	2022-11-07	Gilead Sciences, Inc.	Bridged tricyclic carbamoylpyridone compounds and their pharmaceutical use

2019
- 2019-05-30 CA CA3102063A patent/CA3102063A1/en active Pending
- 2019-05-30 SI SI201930798T patent/SI3805220T1/en unknown
- 2019-05-30 HR HRP20241221TT patent/HRP20241221T1/en unknown
- 2019-05-30 IL IL279051A patent/IL279051B2/en unknown
- 2019-05-30 HU HUE19810498A patent/HUE068170T2/en unknown
- 2019-05-30 PT PT198104986T patent/PT3805220T/en unknown
- 2019-05-30 CR CR20200644A patent/CR20200644A/en unknown
- 2019-05-30 JP JP2020522577A patent/JP7328962B2/en active Active
- 2019-05-30 CN CN202311258763.1A patent/CN117327072A/en active Pending
- 2019-05-30 DK DK19810498.6T patent/DK3805220T3/en active
- 2019-05-30 LT LTEPPCT/JP2019/021446T patent/LT3805220T/en unknown
- 2019-05-30 MD MDE20210334T patent/MD3805220T2/en unknown
- 2019-05-30 AU AU2019277548A patent/AU2019277548B2/en active Active
- 2019-05-30 MA MA52795A patent/MA52795B1/en unknown
- 2019-05-30 SG SG11202011382PA patent/SG11202011382PA/en unknown
- 2019-05-30 CN CN201980050399.5A patent/CN112513042B/en active Active
- 2019-05-30 EP EP23192706.2A patent/EP4257137A3/en active Pending
- 2019-05-30 UA UAA202008303A patent/UA129229C2/en unknown
- 2019-05-30 US US17/058,251 patent/US11649236B2/en active Active
- 2019-05-30 EA EA202092921A patent/EA202092921A1/en unknown
- 2019-05-30 CR CR20230571A patent/CR20230571A/en unknown
- 2019-05-30 MX MX2020012176A patent/MX2020012176A/en unknown
- 2019-05-30 IL IL313474A patent/IL313474A/en unknown
- 2019-05-30 FI FIEP19810498.6T patent/FI3805220T3/en active
- 2019-05-30 KR KR1020247040377A patent/KR20250002769A/en active Pending
- 2019-05-30 SM SM20240330T patent/SMT202400330T1/en unknown
- 2019-05-30 RS RS20240971A patent/RS65891B1/en unknown
- 2019-05-30 EP EP19810498.6A patent/EP3805220B1/en active Active
- 2019-05-30 BR BR112020024077-0A patent/BR112020024077A2/en unknown
- 2019-05-30 PL PL19810498.6T patent/PL3805220T3/en unknown
- 2019-05-30 PE PE2020001863A patent/PE20210477A1/en unknown
- 2019-05-30 KR KR1020207037580A patent/KR102741390B1/en active Active
- 2019-05-30 ES ES19810498T patent/ES2984245T3/en active Active
- 2019-05-30 AR ARP190101467A patent/AR115455A1/en unknown
- 2019-05-30 WO PCT/JP2019/021446 patent/WO2019230858A1/en active IP Right Grant
2020
- 2020-11-13 MX MX2023010377A patent/MX2023010377A/en unknown
- 2020-11-18 CO CONC2020/0014294A patent/CO2020014294A2/en unknown
- 2020-11-18 CL CL2020003002A patent/CL2020003002A1/en unknown
- 2020-11-20 PH PH12020552000A patent/PH12020552000A1/en unknown
- 2020-11-27 DO DO2020000221A patent/DOP2020000221A/en unknown
- 2020-12-04 ZA ZA2020/07567A patent/ZA202007567B/en unknown
2023
- 2023-03-22 US US18/124,827 patent/US12139489B2/en active Active
- 2023-08-03 JP JP2023127333A patent/JP7679427B2/en active Active
2024
- 2024-02-08 AU AU2024200783A patent/AU2024200783A1/en active Pending
- 2024-06-26 US US18/755,191 patent/US20240352015A1/en active Pending

Also Published As

Publication number	Publication date
IL279051B1 (en)	2024-09-01
HUE068170T2 (en)	2024-12-28
PH12020552000A1 (en)	2021-09-27
DK3805220T3 (en)	2024-08-26
RS65891B1 (en)	2024-09-30
EP4257137A3 (en)	2023-11-01
EP3805220B1 (en)	2024-07-31
EA202092921A1 (en)	2021-04-07
MA52795B1 (en)	2024-09-30
SMT202400330T1 (en)	2024-09-16
DOP2020000221A (en)	2021-03-15
CN112513042A (en)	2021-03-16
HRP20241221T1 (en)	2024-12-06
JP7328962B2 (en)	2023-08-17
CL2020003002A1 (en)	2021-04-16
AU2019277548B2 (en)	2023-12-14
MX2020012176A (en)	2021-01-29
PT3805220T (en)	2024-08-16
KR102741390B1 (en)	2024-12-10
IL279051B2 (en)	2025-01-01
US20210122751A1 (en)	2021-04-29
US11649236B2 (en)	2023-05-16
UA129229C2 (en)	2025-02-19
CR20230571A (en)	2024-01-22
CN112513042B (en)	2023-09-29
MD3805220T2 (en)	2024-10-31
JPWO2019230858A1 (en)	2021-06-24
SI3805220T1 (en)	2024-10-30
JP7679427B2 (en)	2025-05-19
ES2984245T3 (en)	2024-10-29
LT3805220T (en)	2024-08-26
BR112020024077A2 (en)	2021-02-09
JP2023145723A (en)	2023-10-11
EP4257137A2 (en)	2023-10-11
EP3805220A1 (en)	2021-04-14
CR20200644A (en)	2021-02-05
CO2020014294A2 (en)	2020-12-21
AR115455A1 (en)	2021-01-20
ZA202007567B (en)	2022-04-28
KR20210015922A (en)	2021-02-10
AU2024200783A1 (en)	2024-02-29
KR20250002769A (en)	2025-01-07
MA52795A (en)	2021-04-14
MX2023010377A (en)	2023-09-12
PE20210477A1 (en)	2021-03-11
EP3805220A4 (en)	2022-01-05
IL279051A (en)	2021-01-31
PL3805220T3 (en)	2024-11-04
CA3102063A1 (en)	2019-12-05
CN117327072A (en)	2024-01-02
WO2019230858A1 (en)	2019-12-05
US12139489B2 (en)	2024-11-12
AU2019277548A1 (en)	2021-01-14
IL313474A (en)	2024-08-01
US20240352015A1 (en)	2024-10-24
FI3805220T3 (en)	2024-08-30
US20230227454A1 (en)	2023-07-20

Publication	Publication Date	Title
ZA202007567B (en)	2022-04-28	Polycyclic carbamoylpyridone derivative
CA187253S (en)	2020-05-06	Bracket
PT3810587T (en)	2022-11-14	Substituted alkoxypyridinyl indolsulfonamides
ZA202007568B (en)	2022-04-28	Polycyclic pyridone derivative
SG11202104993SA (en)	2021-06-29	Anti-cdh6 antibody-pyrrolobenzodiazepine derivative conjugate
IL283990A (en)	2021-07-29	Substituted oxopyridine derivatives
AU201815437S (en)	2018-10-19	bracket
ZA202000970B (en)	2021-07-28	Pentacyclic compound
IL279938A (en)	2021-03-01	Spirochromane derivatives
IL290964A (en)	2022-04-01	2-aminoquinazolinone derivative
PL3796975T3 (en)	2024-02-26	Sulfonylaminobenzamide derivatives
IL280453A (en)	2021-03-25	Benzene derivative
SG11202006837XA (en)	2020-08-28	Dihydroindolizinone derivative
SG11202007979UA (en)	2020-09-29	Dihydrochromene derivative
GB2576143B (en)	2022-09-14	Mount
PL3616997T3 (en)	2021-07-12	Arrangement
GB201806948D0 (en)	2018-06-13	Derivatives
ZAF201800906S (en)	2019-03-27	Bracket
ZAF201800908S (en)	2019-03-27	Bracket
ZAF201800912S (en)	2019-03-27	Bracket
PH32018000041S1 (en)	2018-10-10	Supports